Sign in

CIK 0001756262

  • Large accelerated filer

TransMedics Group, Inc.

Sign in to watch
Ticker
TMDX
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
MA
Entity type
Operating
Phone
+1 978-552-0900
Business address
200 MINUTEMAN ROAD, ANDOVER, MA, 01810
Open-market buys, last 90 days
$109,058
in 1 filing
Open-market sales, last 90 days
$385,464
in 1 filing

Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. TOBIN JAMES R −$385K Director sold 58% of stake
  2. Weill David +$109K Director 1 filing

Reading 31 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-04-01 Carey John F VP of Operations Exercise or conversion · Stock Option (Right to Buy) −1,500 26,489
2022-03-28 Carey John F VP of Operations Exercise or conversion +2,813 $16.14 $45K 3,912
2022-03-28 Carey John F VP of Operations Exercise or conversion +1,530 $2.21 $3K 4,722
2022-03-28 Carey John F VP of Operations Exercise or conversion +157 $0.28 $44 4,879
2022-03-28 Carey John F VP of Operations Sale −4,500 $25.01 $113K 379
2022-03-28 Carey John F VP of Operations Exercise or conversion · Stock Option (Right to Buy) −2,813 8,125
2022-03-28 Carey John F VP of Operations Exercise or conversion · Stock Option (Right to Buy) −1,530 10,743
2022-03-28 Carey John F VP of Operations Exercise or conversion · Stock Option (Right to Buy) −157 27,989
2022-02-22 Carey John F VP of Operations Grant or award · Stock Option (Right to Buy) +38,000 38,000
2022-02-22 Khayal Tamer I Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +52,000 52,000
2022-02-22 DAMME LAURA VP, Clinical Affairs Grant or award · Stock Option (Right to Buy) +38,000 38,000
2022-02-22 Provost Miriam VP of Global Regl. Affairs Grant or award · Stock Option (Right to Buy) +38,000 38,000
2022-02-22 Hassanein Waleed H President & CEO Grant or award · Stock Option (Right to Buy) +250,000 250,000
2022-02-22 Gordon Stephen Chief Financial Officer Grant or award · Stock Option (Right to Buy) +52,000 52,000
2022-01-06 Hassanein Waleed H President & CEO Exercise or conversion +122,371 $0.28 $34K 526,214
2022-01-06 Hassanein Waleed H President & CEO Exercise or conversion · Stock Option (Right to Buy) −122,371 0
2021-12-23 Provost Miriam VP of US Regulatory & FDA Rel. Exercise or conversion +884 $3.22 $3K 9,438
2021-12-23 Provost Miriam VP of US Regulatory & FDA Rel. Exercise or conversion · Stock Option (Right to Buy) −884 20,881
2021-12-15 TOBIN JAMES R Director Gift −25,500 399,137
2021-11-29 KANIA EDWIN M JR Director Purchase +25,938 $22.14 $574K 228,831

Page 40 of 49 · 980 trades